PAVmed (PAVM) Competitors $0.43 -0.01 (-2.21%) Closing price 09/25/2025 04:00 PM EasternExtended Trading$0.44 +0.01 (+2.30%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAVM vs. ECOR, RBOT, POCI, CLGN, COCH, VVOS, STRR, PETV, RVP, and ICUShould you be buying PAVmed stock or one of its competitors? The main competitors of PAVmed include electroCore (ECOR), Vicarious Surgical (RBOT), Precision Optics (POCI), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), Vivos Therapeutics (VVOS), Star Equity (STRR), PetVivo (PETV), Retractable Technologies (RVP), and SeaStar Medical (ICU). These companies are all part of the "medical equipment" industry. PAVmed vs. Its Competitors electroCore Vicarious Surgical Precision Optics CollPlant Biotechnologies Envoy Medical Vivos Therapeutics Star Equity PetVivo Retractable Technologies SeaStar Medical PAVmed (NASDAQ:PAVM) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk. Does the media refer more to PAVM or ECOR? In the previous week, electroCore had 3 more articles in the media than PAVmed. MarketBeat recorded 4 mentions for electroCore and 1 mentions for PAVmed. PAVmed's average media sentiment score of 1.89 beat electroCore's score of 0.78 indicating that PAVmed is being referred to more favorably in the media. Company Overall Sentiment PAVmed Very Positive electroCore Positive Which has more volatility & risk, PAVM or ECOR? PAVmed has a beta of 1.09, suggesting that its share price is 9% more volatile than the S&P 500. Comparatively, electroCore has a beta of 0.36, suggesting that its share price is 64% less volatile than the S&P 500. Do insiders and institutionals believe in PAVM or ECOR? 19.9% of PAVmed shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 7.3% of PAVmed shares are owned by insiders. Comparatively, 13.8% of electroCore shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts recommend PAVM or ECOR? PAVmed presently has a consensus price target of $19.00, indicating a potential upside of 4,317.58%. electroCore has a consensus price target of $25.50, indicating a potential upside of 429.05%. Given PAVmed's higher probable upside, equities research analysts clearly believe PAVmed is more favorable than electroCore.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PAVmed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00electroCore 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation & earnings, PAVM or ECOR? PAVmed has higher earnings, but lower revenue than electroCore. electroCore is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPAVmed$2.99M3.15$39.79M$1.160.37electroCore$25.18M1.45-$11.89M-$1.62-2.98 Is PAVM or ECOR more profitable? PAVmed has a net margin of 7,144.80% compared to electroCore's net margin of -47.84%. PAVmed's return on equity of 0.00% beat electroCore's return on equity.Company Net Margins Return on Equity Return on Assets PAVmed7,144.80% N/A -20.96% electroCore -47.84%-221.93%-69.17% SummaryPAVmed beats electroCore on 10 of the 15 factors compared between the two stocks. Get PAVmed News Delivered to You Automatically Sign up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PAVM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAVM vs. The Competition Export to ExcelMetricPAVmedMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.65M$6.74B$5.74B$10.39BDividend YieldN/A1.22%5.75%4.64%P/E Ratio0.3725.0375.9526.11Price / Sales3.15196.58546.83124.93Price / CashN/A21.5437.5461.24Price / Book-0.475.0112.666.30Net Income$39.79M$178.07M$3.29B$271.03M7 Day Performance-2.25%-0.74%0.25%-0.20%1 Month Performance-17.13%5.20%2.80%5.77%1 Year Performance-62.92%21.95%63.42%27.62% PAVmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAVMPAVmed4.2495 of 5 stars$0.43-2.2%$19.00+4,317.6%-62.6%$9.65M$2.99M0.3790Positive NewsECORelectroCore2.2854 of 5 stars$4.83+1.9%$25.50+428.0%-29.1%$35.95M$27.70M-2.9850RBOTVicarious Surgical2.0249 of 5 stars$5.85+0.5%$7.00+19.7%+0.8%$34.52MN/A-0.58210News CoveragePOCIPrecision Optics0.5082 of 5 stars$4.39-0.5%N/A-24.5%$33.77M$19.10M-4.9380Positive NewsUpcoming EarningsGap UpCLGNCollPlant Biotechnologies2.6348 of 5 stars$2.63+0.4%$11.50+337.3%-40.8%$33.32M$2.40M-2.3370COCHEnvoy Medical2.1464 of 5 stars$1.33+3.1%$9.25+595.5%-76.0%$27.76M$222K-0.9334News CoverageVVOSVivos Therapeutics2.6052 of 5 stars$3.38-2.6%$4.92+45.5%+3.4%$26.04M$15.03M-2.01160Positive NewsSTRRStar Equity1.2367 of 5 stars$9.81+4.7%$5.00-49.0%+179.1%$25.82M$140.06M-7.551,300Positive NewsPETVPetVivoN/A$0.95+5.9%N/A+90.5%$25.11M$1.05M-2.1220News CoverageRVPRetractable Technologies1.3548 of 5 stars$0.82flatN/A+14.9%$24.55M$38.16M-1.52240News CoveragePositive NewsICUSeaStar Medical0.3432 of 5 stars$0.84-3.1%N/A-86.5%$24.29M$140K-0.322News CoverageGap Down Related Companies and Tools Related Companies electroCore Competitors Vicarious Surgical Competitors Precision Optics Competitors CollPlant Biotechnologies Competitors Envoy Medical Competitors Vivos Therapeutics Competitors Star Equity Competitors PetVivo Competitors Retractable Technologies Competitors SeaStar Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAVM) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredChina Targets MAGA In Stealth Trade War TacticsChina is deliberately targeting the economic backbone of conservative America - The very industries that supp...Goldco Precious Metals | SponsoredCollege grad makes $64,000 a monthNothing hurts like a missed opportunity... And with AI stocks like Nvidia, Palantir, and Oracle continuing...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PAVmed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PAVmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
